---
document_datetime: 2023-09-21 20:53:06
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/atripla-epar-all-authorised-presentations_en.pdf
document_name: atripla-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.3982271
conversion_datetime: 2025-12-22 13:51:35.45558
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
<!-- image -->

EU number EU/1/07/430/001

Invented name

Strength

Pharmaceutical Form Film-coated tablet

Route of administration

Packaging

EU/1/07/430/002

Atripla Atripla 600 mg/200 mg/245 mg * Film-coated tablet Oral use 1/1 Medicinal product no longer authorised

600 mg/200 mg/245 mg *

Oral use

Bottle (HDPE/alu)

Bottle (HDPE/alu)

* efavirenz / emtricitabine / tenofovir disoproxil (as fumarate)